Search research articles
Contact Us
Filters
Showing results (451-460 of 481) with videos related to
Page
of 49
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1989
Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium
J Klastersky, J P Sculier, G Bureau, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 6, 2000
A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer. The European Lung Cancer Working Party. 101473.1044@compuserve.com
J P Sculier, J J Lafitte, T Berghmans, et al.
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique
|
January 1, 1985
[Salicylates and cortico-adrenal stimulation: myth or reality?]
H Van Cauwenberge, J Lecomte, P Franchimont, et al.
Veterinary Microbiology
|
December 1, 1988
Further biological, serological and biochemical characterization of North American, European and Southeast Asian strains of bovine herpesvirus 1 compared with other alphaherpesvirinae members
P Trépanier, H C Minocha, A L Ibrahim, et al.
Revue Medicale De Liege
|
November 1, 1980
[Diagnosis of secreting pheochromocytoma]
P Bovy, J Juchmès, V Bourdon, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 12, 2005
A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma
T Berghmans, J J Lafitte, M Paesmans, et al.
Frontiers in Oncology
|
September 7, 2013
Variable Expression of GLIPR1 Correlates with Invasive Potential in Melanoma Cells
Anshul Awasthi, Adele G Woolley, Fabienne J Lecomte, et al.
International Journal of Oncology
|
May 10, 2011
A phase-ii study testing a combination chemotherapy with epirubicin and vindesine as 2nd line treatment for patients with advanced non-small-cell lung-cancer
J Sculier, G Bureau, J Thiriaux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2002
A phase II randomised trial comparing the cisplatin-etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancer
J P Sculier, J J Lafitte, J Lecomte, et al.
Journal of the American Society of Nephrology : JASN
|
January 5, 2007
Nitrite-derived nitric oxide protects the rat kidney against ischemia/reperfusion injury in vivo: role for xanthine oxidoreductase
Pinpat Tripatara, Nimesh S A Patel, Andrew Webb, et al.
Page
of 49
Search research articles
Search
Showing results (451-460 of 481) with videos related to
Sort By:
Page
of 49
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1989
Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium
J Klastersky, J P Sculier, G Bureau, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 6, 2000
A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer. The European Lung Cancer Working Party. 101473.1044@compuserve.com
J P Sculier, J J Lafitte, T Berghmans, et al.
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique
|
January 1, 1985
[Salicylates and cortico-adrenal stimulation: myth or reality?]
H Van Cauwenberge, J Lecomte, P Franchimont, et al.
Veterinary Microbiology
|
December 1, 1988
Further biological, serological and biochemical characterization of North American, European and Southeast Asian strains of bovine herpesvirus 1 compared with other alphaherpesvirinae members
P Trépanier, H C Minocha, A L Ibrahim, et al.
Revue Medicale De Liege
|
November 1, 1980
[Diagnosis of secreting pheochromocytoma]
P Bovy, J Juchmès, V Bourdon, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 12, 2005
A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma
T Berghmans, J J Lafitte, M Paesmans, et al.
Frontiers in Oncology
|
September 7, 2013
Variable Expression of GLIPR1 Correlates with Invasive Potential in Melanoma Cells
Anshul Awasthi, Adele G Woolley, Fabienne J Lecomte, et al.
International Journal of Oncology
|
May 10, 2011
A phase-ii study testing a combination chemotherapy with epirubicin and vindesine as 2nd line treatment for patients with advanced non-small-cell lung-cancer
J Sculier, G Bureau, J Thiriaux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2002
A phase II randomised trial comparing the cisplatin-etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancer
J P Sculier, J J Lafitte, J Lecomte, et al.
Journal of the American Society of Nephrology : JASN
|
January 5, 2007
Nitrite-derived nitric oxide protects the rat kidney against ischemia/reperfusion injury in vivo: role for xanthine oxidoreductase
Pinpat Tripatara, Nimesh S A Patel, Andrew Webb, et al.
Page
of 49